Cocrystal Pharma COCP
NASDAQ COCP
$0.96 +0.02 (+1.81%)
As of: Oct 21, 2026 · 3:20 PM EDT

Cocrystal Pharma (COCP) EV to EBITDA (2012 - 2013)

Updated

Analysis

Cocrystal Pharma (COCP) EV to EBITDA (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cocrystal Pharma 13.24 Mn -8.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 292,120.13
Dec 31, 2012 13,191.96
API Access

Cocrystal Pharma EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=COCP&period=max&api_key=YOUR_API_KEY